Medtronic on Nov. 21 posted its financial results for the second quarter of the fiscal year 2024.

The last few years have been tough on spine device companies.

ZimVie in 2023 saw decreases in its revenue, but the company also saw milestones in its spine portfolio.

The top executives at large orthopedic and spine device companies received millions of dollars in total compensation for the 2022 fiscal year, according to reports filed with the U.S. Securities & Exchange Commission.

Boston Scientific closed its acquisitioon of Relievant Medsystems, which is behind the Intracept intraosseous nerve ablation system, according to a Nov. 17 news release. 

Aurora Spine has announced its financial results for the third quarter of 2023, seeing a 7.7% growth in sales from the same quarter last year. 

Visie, a company focused spine and orthopedic imaging, added three medtech leaders to its board and leadership, according to a Nov. 14 news release. 

NGMedical GmbH's Move-C device made its debut in Taiwan, according to a Nov. 14 news release. 

VySpine earned FDA clearance for its ClariVy OsteoVy PEKK device for one-level cervical interbody fusion, the company said in a Nov. 14 news release. 

Spine surgeons are constantly looking for better products and instruments that help improve their patients’ outcomes. This includes cutting-edge tools built on ideas and knowledge of experienced spine surgeons, with the highest-quality metals and innovative approaches like 3D printing.

Symptomatic lumbar degenerative disc disease (DDD) is a major cause of back pain, missed work days, and healthcare utilization.1; 2 If left untreated, it can lead to bone spurs, spinal canal compression, debilitating pain, herniated discs, and loss of bladder control.3; 4

Large commercial payers in Illinois, Texas, New Mexico and Oklahoma now cover one- and two-level lumbar disc replacement. 

Artificial disc replacement technology has made significant growth in 2023. Here are seven key developments to know:

Here are 10 spine devices earning FDA approvals and clearances since Oct. 1.

John Booth is retiring from his role as CEO and director of Spineology, a minimally invasive surgery technology company.

Thousands of prospective patients have shown interest in Neuralink, and the company overseen by Elon Musk has ambitious plans for upcoming human trials, Bloomberg reported Nov. 6.

Stryker, Johnson & Johnson and Zimmer Biomet posted their third quarter financial results for 2023, and data on their orthopedic sales.

Globus Medical reported $383.6 million in global net sales during the third quarter, according to a Nov. 7 news release.

Spine medtech company Alphatec recently reported $118 million in total revenue for the third quarter of 2023. 

Orthofix's WaveForm L interbody sytem is out in a full commercial release, the company said Nov. 6.